Welcome to Eureka, an online community for scientists to explore, connect and share big ideas.


Read Charles River's scientific blog.


Blog: Ebola’s Collateral Damage

A Huffington Post commentary about the escalating Ebola crisis in West Africa notes the full extent of the outbreak’s damage will be hard to measure. Unlike the fairly precise death data being collected and reported on Ebola, data on other diseases – from malaria to diarrheal disease and tuberculosis—are outdated and imprecise.

Read More »

Blog: Diabetes Complications: CVS Disease

Novel therapies are helping reduce the rate of cardiovascular diseases related to diabetes, but there is a need to de-risk these agents before they reach the clinic. The Diabetes Complications Consortium, set up to share data on phenotypic mouse models, is trying to help researchers meet that goal.

Read More »


Listen to Charles River scientists share their recent research in these brief podcasts.


Blog: High-Value Pathology

Regulatory requirements for preclinical safety and efficacy studies of cellular therapeutic agents tend to be more fluid than those for standard toxicology studies. Here are five tips that can help make the process more efficient.

Read More »

Blog: Diabetes Complications: A Long and Lethal List

To say that diabetes is a public health problem is an understatement. Virtually all organ systems are impaired in the face of diabetes. There is no doubt we have made inroads into treating the many complications of diabetes, but as this first in our four-part Eureka series points out, there is also a lot of room for improvement.

Read More »

Blog: Diabetes Complications: Retinal Disease

Diabetic retinopathy, a disease of the retinal blood vessels, is a leading cause of blindness in North America. Fortunately, advances in technology are giving researchers better tools to evaluate the condition in animal models. The second in a series on diabetes complications.

Read More »

Blog: On the Trail of Ebola

As the deadly Ebola outbreak in West Africa continues to spread, finding effective treatments and a vaccine has become an urgent public health priority. The California scientist heading up a new consortium created to fight Ebola talks about some of the progress researchers have made in cracking the virus.

Read More »


Watch videos from Charles River and our industry colleagues.


What's New

Crusading for Science
High-Value Pathology
Ebola’s Collateral Damage

Twitter Feed

Industry Blogs

Talking Points for When People Who Don’t Get Social Media as a News Platform
South Dakota Gov Daugaard Recieves BIO Food & Ag Award
FDA Basics Webinar December 11th: 20 Years Later – Returning to FDA to Regulate Tobacco
Big Journals, Big Retractions
Learn Biotech Basics in Biotech 101!
Living With Cancer: Making Room
Quantum Short 2014 Film Contest Accepting Entries
Close-Up Aerial Photos of Africa’s Last Elephants